Renal and Vascular Effects of Combined SGLT2 and Angiotensin-Converting Enzyme Inhibition

The cardiorenal effects of sodium-glucose cotransporter 2 inhibition (empagliflozin 25 mg QD) combined with angiotensin-converting enzyme inhibition (ramipril 10 mg QD) were assessed in this mechanistic study in patients with type 1 diabetes with potential renal hyperfiltration. METHODS: Thirty pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Lytvyn, Yuliya, Kimura, Karen, Peter, Nuala, Lai, Vesta, Tse, Josephine, Cham, Leslie, Perkins, Bruce A., Soleymanlou, Nima, Cherney, David Z.I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354594/
https://www.ncbi.nlm.nih.gov/pubmed/35862082
http://dx.doi.org/10.1161/CIRCULATIONAHA.122.059150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354594/
https://www.ncbi.nlm.nih.gov/pubmed/35862082
http://dx.doi.org/10.1161/CIRCULATIONAHA.122.059150

Ejemplares similares